GEODE CAPITAL MANAGEMENT, LLC
Position in SLS — SELLAS Life Sciences Group, Inc.
CIK 1214717
BOSTON, MA
Position in SLS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$72,090,422
+$55,540,100 QoQ
Shares Held
4,884,175
+24.8% QoQ
Ownership
2.42%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 192 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SLS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. SLS ranks #64 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in SLS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $72,090,422 | 4,884,175 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $16,550,322 | 3,912,606 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $11,601,559 | 3,077,337 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $3,645,658 | 2,264,384 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,818,936 | 2,200,428 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $886,075 | 820,440 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $762,886 | 733,546 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $756,488 | 605,191 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $615,239 | 517,008 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $275,793 | 273,063 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $260,339 | 245,603 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $386,388 | 235,603 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $295,263 | 188,066 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $268,934 | 188,066 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $443,835 | 188,066 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $292,332 | 144,719 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $322,723 | 144,719 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $914,465 | 136,896 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $739,919 | 133,801 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,225,617 | 133,801 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,124,840 | 101,337 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $810,505 | 94,907 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $199,951 | 34,415 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $161,422 | 60,914 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $177,599 | 60,614 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $91,321 | 52,787 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||